首页 > 最新文献

Journal of Pediatrics最新文献

英文 中文
Long-Term Effects of Fetal Growth Restriction on Cardiovascular Structure and Function: A Cohort Study in Growth-Discordant Identical Twins. 胎儿生长受限对心血管结构和功能的长期影响:一项生长不一致的同卵双胞胎队列研究。
IF 3.5 2区 医学 Q1 PEDIATRICS Pub Date : 2026-01-19 DOI: 10.1016/j.jpeds.2026.114998
Jip A Spekman, Sophie G Groene, Monique C Haak, Lisette M Harteveld, Francisca P de Klerk-Voll, Eric de Groot, Jeanine M M van Klink, Enrico Lopriore, Arno A W Roest

Objective: To investigate the effect of fetal growth restriction (FGR) on cardiovascular structure and function in childhood in a growth-discordant identical twin model, thereby adjusting naturally for genetic, obstetric, and environmental confounding factors.

Study design: This study is part of the LEMON cohort study of growth-discordant identical twins born at the Leiden University Medical Center, The Netherlands. Echocardiography was prospectively performed in 42 twin pairs aged between 5 and 17 years. Growth discordance was defined as a birth weight discordance ≥20%. Outcome measures were compared between the smaller and larger twin and included structural measures (left ventricular [LV] dimensions and carotid intima-media thickness) as well as functional measures (LV systolic and diastolic function using Doppler and LV strain imaging, and aortic pulsed wave velocity).

Results: Median gestational age at birth was 34.1 weeks (IQR 31.6-36.0) with median birth weights of 1471 g (IQR 1114-1876) and 2025 g (IQR 1623-2705) for the smaller and larger twin, respectively. Median age at echocardiography was 11 years (IQR 9-14). Smaller twins presented with significantly lower LV global longitudinal strain (-19.6% vs -20.7%), and higher mitral peak E and A velocities, and mitral E/e' ratio compared with larger co-twins. No within-pair differences were found regarding structural cardiovascular parameters, carotid intima-media thickness and aortic pulsed wave velocity.

Conclusions: In a growth-discordant identical twin model, FGR is associated with subclinical changes in myocardial structure and systolic and diastolic LV function in the smaller growth-restricted twin compared with the larger appropriately-grown co-twin. This finding indicates that adverse cardiovascular remodeling after FGR persists into childhood, potentially influencing long-term risk of cardiovascular disease.

Trial registration: International Clinical Trial Registry Platform ID NL9833 (https://trialsearch.who.int/).

目的:探讨胎儿生长受限(FGR)对生长不协调同卵双生儿模型儿童期心血管结构和功能的影响,从而对遗传、产科和环境混杂因素进行自然调整。研究设计:本研究是LEMON队列研究的一部分,研究对象是荷兰莱顿大学医学中心出生的生长不协调的同卵双胞胎。前瞻性地对42对5 - 17岁的双胞胎进行超声心动图检查。生长不一致定义为出生体重不一致≥20%。比较小双胞胎和大双胞胎的预后指标,包括结构指标(左心室(LV)尺寸和颈动脉内膜-中膜厚度[cIMT])以及功能指标(采用多普勒和左室应变成像的左室收缩和舒张功能,以及主动脉脉冲波速度[aPWV])。结果:出生时中位胎龄为34.1周(IQR 31.6-36.0),中位出生体重分别为1471克(IQR 1114-1876)和2025克(IQR 1623-2705)。超声心动图的中位年龄为11岁(IQR 9-14)。与体型较大的双胞胎相比,体型较小的双胞胎LV整体纵向应变明显较低(-19.6% vs -20.7%),二尖瓣峰值E和A速度以及二尖瓣E/ E′比均较高。在心血管结构参数、cIMT和aPWV方面未发现配对内差异。结论:在生长不协调的同卵双胞胎模型中,与发育正常的同卵双胞胎相比,生长受限的小双胞胎的FGR与心肌结构和左室收缩和舒张功能的亚临床变化有关。这一发现表明,FGR后的不良心血管重塑持续到儿童期,可能影响心血管疾病的长期风险。
{"title":"Long-Term Effects of Fetal Growth Restriction on Cardiovascular Structure and Function: A Cohort Study in Growth-Discordant Identical Twins.","authors":"Jip A Spekman, Sophie G Groene, Monique C Haak, Lisette M Harteveld, Francisca P de Klerk-Voll, Eric de Groot, Jeanine M M van Klink, Enrico Lopriore, Arno A W Roest","doi":"10.1016/j.jpeds.2026.114998","DOIUrl":"10.1016/j.jpeds.2026.114998","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the effect of fetal growth restriction (FGR) on cardiovascular structure and function in childhood in a growth-discordant identical twin model, thereby adjusting naturally for genetic, obstetric, and environmental confounding factors.</p><p><strong>Study design: </strong>This study is part of the LEMON cohort study of growth-discordant identical twins born at the Leiden University Medical Center, The Netherlands. Echocardiography was prospectively performed in 42 twin pairs aged between 5 and 17 years. Growth discordance was defined as a birth weight discordance ≥20%. Outcome measures were compared between the smaller and larger twin and included structural measures (left ventricular [LV] dimensions and carotid intima-media thickness) as well as functional measures (LV systolic and diastolic function using Doppler and LV strain imaging, and aortic pulsed wave velocity).</p><p><strong>Results: </strong>Median gestational age at birth was 34.1 weeks (IQR 31.6-36.0) with median birth weights of 1471 g (IQR 1114-1876) and 2025 g (IQR 1623-2705) for the smaller and larger twin, respectively. Median age at echocardiography was 11 years (IQR 9-14). Smaller twins presented with significantly lower LV global longitudinal strain (-19.6% vs -20.7%), and higher mitral peak E and A velocities, and mitral E/e' ratio compared with larger co-twins. No within-pair differences were found regarding structural cardiovascular parameters, carotid intima-media thickness and aortic pulsed wave velocity.</p><p><strong>Conclusions: </strong>In a growth-discordant identical twin model, FGR is associated with subclinical changes in myocardial structure and systolic and diastolic LV function in the smaller growth-restricted twin compared with the larger appropriately-grown co-twin. This finding indicates that adverse cardiovascular remodeling after FGR persists into childhood, potentially influencing long-term risk of cardiovascular disease.</p><p><strong>Trial registration: </strong>International Clinical Trial Registry Platform ID NL9833 (https://trialsearch.who.int/).</p>","PeriodicalId":54774,"journal":{"name":"Journal of Pediatrics","volume":" ","pages":"114998"},"PeriodicalIF":3.5,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146020878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Nonhemodynamically Significant Patent Ductus Arteriosus on Pulmonary Function in Premature Neonates. 非血流动力学意义的动脉导管未闭对早产儿肺功能的影响。
IF 3.5 2区 医学 Q1 PEDIATRICS Pub Date : 2026-01-19 DOI: 10.1016/j.jpeds.2026.115000
Patrick D Evers, Austin F Menezes, Brian Scottoline, Cindy T McEvoy, Paul J Critser, Brian K Jordan

Objective: To quantify the impact of nonhemodynamically significant patent ductus arteriosus (non-hsPDA) on pulmonary function in neonates.

Study design: We analyzed a retrospective cohort of very low birthweight (<1500 g) infants born <32 weeks' gestation admitted to a single tertiary neonatal intensive care unit between 2019 and 2023 who underwent both echocardiography and pulmonary function testing at approximately 34 weeks postmenstrual age. Infants with ventricular or atrial septal defects were excluded. Passive respiratory compliance (Crs) was compared among infants with hsPDA, non-hsPDA, and age-matched controls without PDA using one-sided t-tests and ANOVA, with multivariable regression controlling for birth weight and length.

Results: Twenty-four infants were analyzed (8 hsPDA, 8 non-hsPDA, 8 controls). Mean Crs was significantly reduced in both hsPDA (0.83 ± 0.34 mL/cmH2O/kg) and non-hsPDA (0.92 ± 0.21) groups compared with controls (1.23 ± 0.34; P < .05). The presence of PDA demonstrated a stepwise inverse relationship with Crs that persisted after adjustment for covariates.

Conclusions: Even non-hsPDAs are associated with measurable reductions in pulmonary compliance among preterm infants. These findings suggest that current binary classifications of PDA significance may underestimate pulmonary impact and support re-evaluation of management thresholds for "non-significant" shunts.

目的:量化非血流动力学意义的PDA(非hspda)对新生儿肺功能的影响。研究设计:我们分析了一个极低出生体重的回顾性队列(结果:分析了24名婴儿(8名hsPDA, 8名非hsPDA, 8名对照)。与对照组(1.23±0.34)相比,hsPDA组(0.83±0.34 mL/cmH2O/kg)和非hsPDA组(0.92±0.21)的平均Crs均显著降低。结论:即使是非血流动力学显著的pda也与早产儿肺顺应性的可测量降低相关。这些发现表明,目前对PDA重要性的二元分类可能低估了对肺部的影响,并支持对“非显著”分流的管理阈值的重新评估。
{"title":"Impact of Nonhemodynamically Significant Patent Ductus Arteriosus on Pulmonary Function in Premature Neonates.","authors":"Patrick D Evers, Austin F Menezes, Brian Scottoline, Cindy T McEvoy, Paul J Critser, Brian K Jordan","doi":"10.1016/j.jpeds.2026.115000","DOIUrl":"10.1016/j.jpeds.2026.115000","url":null,"abstract":"<p><strong>Objective: </strong>To quantify the impact of nonhemodynamically significant patent ductus arteriosus (non-hsPDA) on pulmonary function in neonates.</p><p><strong>Study design: </strong>We analyzed a retrospective cohort of very low birthweight (<1500 g) infants born <32 weeks' gestation admitted to a single tertiary neonatal intensive care unit between 2019 and 2023 who underwent both echocardiography and pulmonary function testing at approximately 34 weeks postmenstrual age. Infants with ventricular or atrial septal defects were excluded. Passive respiratory compliance (Crs) was compared among infants with hsPDA, non-hsPDA, and age-matched controls without PDA using one-sided t-tests and ANOVA, with multivariable regression controlling for birth weight and length.</p><p><strong>Results: </strong>Twenty-four infants were analyzed (8 hsPDA, 8 non-hsPDA, 8 controls). Mean Crs was significantly reduced in both hsPDA (0.83 ± 0.34 mL/cmH<sub>2</sub>O/kg) and non-hsPDA (0.92 ± 0.21) groups compared with controls (1.23 ± 0.34; P < .05). The presence of PDA demonstrated a stepwise inverse relationship with Crs that persisted after adjustment for covariates.</p><p><strong>Conclusions: </strong>Even non-hsPDAs are associated with measurable reductions in pulmonary compliance among preterm infants. These findings suggest that current binary classifications of PDA significance may underestimate pulmonary impact and support re-evaluation of management thresholds for \"non-significant\" shunts.</p>","PeriodicalId":54774,"journal":{"name":"Journal of Pediatrics","volume":" ","pages":"115000"},"PeriodicalIF":3.5,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12860412/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146020889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-Acute Dyslipidemia and Abnormal Body Mass Index in Children and Adolescents with COVID-19: A Cohort Study from the RECOVER Initiative 儿童和青少年COVID-19急性后血脂异常和BMI异常:来自康复计划的队列研究
IF 3.5 2区 医学 Q1 PEDIATRICS Pub Date : 2026-01-19 DOI: 10.1016/j.jpeds.2026.114996
Yuqing Lei MS , Ting Zhou MD, PhD , Bingyu Zhang MS , Dazheng Zhang PhD , Huilin Tang PhD , Jiajie Chen PhD , Qiong Wu PhD , Lu Li BS , L. Charles Bailey MD, PhD , Michael J. Becich MD, PhD , Saul Blecker MD, MHS , Dimitri A. Christakis MD, MPH , Daniel Fort PhD, MPH , Sharon J. Herring MD, MPH , Wenke Hwang PhD , Amrik Singh Khalsa MD, MSc, FAAP, FACP , Susan Kim MD, MMSc , David M. Liebovitz MD , Abu Saleh Mohammad Mosa PhD, MS, FAMIA , Suchitra Rao MBBS, MSCS , Yong Chen PhD

Objective

To evaluate the risks of incident dyslipidemia and abnormal body mass index (BMI) during the 28-179-day postacute phase after documented SARS-CoV-2 infection in a large pediatric sample.

Study design

A retrospective cohort study using the Researching COVID to Enhance Recovery pediatric electronic health record datasets from 25 US children's hospitals and health institutions, from March 2020 to September 2023. This study included 384 289 COVID-19-positive patients aged 0-21 years for dyslipidemia analyses and 285 559 aged 2-21 years for BMI analyses, each with at least 6 months of follow-up. COVID-19-negative controls included 1 080 413 and 817 315 patients, respectively. SARS-CoV-2 infection was defined by a positive polymerase chain reaction, antigen, or serologic test; a clinical diagnosis of COVID-19; or a documented diagnosis of post-acute sequelae of SARS-CoV-2. Incident dyslipidemia and abnormal BMI were identified using age-specific laboratory or anthropometric thresholds. Adjusted relative risks (aRRs) were estimated using propensity-score-stratified modified Poisson regression with multiple sensitivity analyses.

Results

During the postacute phase, the COVID-19-positive cohort had higher rates of new-onset composite dyslipidemia (aRR 1.24; 95% CI 1.18-1.29) and abnormal BMI (aRR 1.15; 95% CI, 1.12-1.18). Results were robust to sensitivity and stratified analyses.

Conclusions

Children and adolescents with documented COVID-19 infection were associated with an increased risk of new-onset dyslipidemia and abnormal BMI during the postacute phase, highlighting the need for metabolic monitoring after infection.
目的:评估大量儿童SARS-CoV-2感染后急性期28-179天内发生血脂异常和体重指数(BMI)异常的风险。研究设计:一项回顾性队列研究,使用来自25家美国儿童医院和卫生机构的RECOVER儿童电子健康记录(EHR)数据集,时间为2020年3月至2023年9月。该研究包括384289名年龄在0-21岁的covid -19阳性患者进行血脂异常分析,285559名年龄在2-21岁的患者进行BMI分析,每名患者至少进行6个月的随访。阴性对照分别为1080413例和817315例。SARS-CoV-2感染的定义是聚合酶链反应(PCR)、抗原或血清学检测阳性;1例COVID-19临床诊断;或确诊为SARS-CoV-2急性后后遗症(PASC)。使用特定年龄的实验室或人体测量阈值确定偶发的血脂异常和异常BMI。校正相对危险度(aRRs)采用倾向评分分层修正泊松回归与多敏感性分析进行估计。结果:急性期后,新发复合血脂异常(aRR 1.24, 95% CI 1.18-1.29)和BMI异常(aRR 1.15, 95% CI 1.12-1.18)发生率较高。结果对敏感性和分层分析具有稳健性。结论:记录在案的COVID-19感染儿童和青少年与急性期后新发血脂异常和BMI异常的风险增加相关,突出了感染后代谢监测的必要性。
{"title":"Post-Acute Dyslipidemia and Abnormal Body Mass Index in Children and Adolescents with COVID-19: A Cohort Study from the RECOVER Initiative","authors":"Yuqing Lei MS ,&nbsp;Ting Zhou MD, PhD ,&nbsp;Bingyu Zhang MS ,&nbsp;Dazheng Zhang PhD ,&nbsp;Huilin Tang PhD ,&nbsp;Jiajie Chen PhD ,&nbsp;Qiong Wu PhD ,&nbsp;Lu Li BS ,&nbsp;L. Charles Bailey MD, PhD ,&nbsp;Michael J. Becich MD, PhD ,&nbsp;Saul Blecker MD, MHS ,&nbsp;Dimitri A. Christakis MD, MPH ,&nbsp;Daniel Fort PhD, MPH ,&nbsp;Sharon J. Herring MD, MPH ,&nbsp;Wenke Hwang PhD ,&nbsp;Amrik Singh Khalsa MD, MSc, FAAP, FACP ,&nbsp;Susan Kim MD, MMSc ,&nbsp;David M. Liebovitz MD ,&nbsp;Abu Saleh Mohammad Mosa PhD, MS, FAMIA ,&nbsp;Suchitra Rao MBBS, MSCS ,&nbsp;Yong Chen PhD","doi":"10.1016/j.jpeds.2026.114996","DOIUrl":"10.1016/j.jpeds.2026.114996","url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate the risks of incident dyslipidemia and abnormal body mass index (BMI) during the 28-179-day postacute phase after documented SARS-CoV-2 infection in a large pediatric sample.</div></div><div><h3>Study design</h3><div>A retrospective cohort study using the Researching COVID to Enhance Recovery pediatric electronic health record datasets from 25 US children's hospitals and health institutions, from March 2020 to September 2023. This study included 384 289 COVID-19-positive patients aged 0-21 years for dyslipidemia analyses and 285 559 aged 2-21 years for BMI analyses, each with at least 6 months of follow-up. COVID-19-negative controls included 1 080 413 and 817 315 patients, respectively. SARS-CoV-2 infection was defined by a positive polymerase chain reaction, antigen, or serologic test; a clinical diagnosis of COVID-19; or a documented diagnosis of post-acute sequelae of SARS-CoV-2. Incident dyslipidemia and abnormal BMI were identified using age-specific laboratory or anthropometric thresholds. Adjusted relative risks (aRRs) were estimated using propensity-score-stratified modified Poisson regression with multiple sensitivity analyses.</div></div><div><h3>Results</h3><div>During the postacute phase, the COVID-19-positive cohort had higher rates of new-onset composite dyslipidemia (aRR 1.24; 95% CI 1.18-1.29) and abnormal BMI (aRR 1.15; 95% CI, 1.12-1.18). Results were robust to sensitivity and stratified analyses.</div></div><div><h3>Conclusions</h3><div>Children and adolescents with documented COVID-19 infection were associated with an increased risk of new-onset dyslipidemia and abnormal BMI during the postacute phase, highlighting the need for metabolic monitoring after infection.</div></div>","PeriodicalId":54774,"journal":{"name":"Journal of Pediatrics","volume":"291 ","pages":"Article 114996"},"PeriodicalIF":3.5,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146020805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Successful Bacteriophage Treatment of a Recalcitrant Intra-Abdominal Infection Caused by Multidrug-Resistant Pseudomonas aeruginosa in a 2-Year-Old Child 噬菌体成功治疗1例2岁儿童多重耐药铜绿假单胞菌引起的难治性腹腔感染。
IF 3.5 2区 医学 Q1 PEDIATRICS Pub Date : 2026-01-19 DOI: 10.1016/j.jpeds.2026.115005
Sanchi Malhotra MD , Keiko C. Salazar PhD , Neema Pithia MD , Ishminder Kaur MD , Kristina Adachi MD , Nanda Ramachandar MD , Austin L. Terwilliger PhD , Anthony Maresso PhD , Robert S. Venick MD , Suzanne V. McDiarmid MD , John S. Bradley MD
Antimicrobial resistance is life-threatening to pediatric patients with medical complexity who receive multiple courses of broad-spectrum antibiotics. Bacteriophages offer a safe treatment alternative when our antibiotic armamentarium is no longer sufficient. We describe successful use of bacteriophage therapy on a patient with a recalcitrant Pseudomonas aeruginosa infection after receiving a multiorgan transplant.
对于接受多个疗程广谱抗生素治疗的复杂儿科患者,抗菌素耐药性是危及生命的。当我们的抗生素储备不再足够时,噬菌体提供了一种安全的治疗选择。我们描述了成功使用噬菌体治疗的病人顽固性铜绿假单胞菌感染后接受多器官移植。
{"title":"Successful Bacteriophage Treatment of a Recalcitrant Intra-Abdominal Infection Caused by Multidrug-Resistant Pseudomonas aeruginosa in a 2-Year-Old Child","authors":"Sanchi Malhotra MD ,&nbsp;Keiko C. Salazar PhD ,&nbsp;Neema Pithia MD ,&nbsp;Ishminder Kaur MD ,&nbsp;Kristina Adachi MD ,&nbsp;Nanda Ramachandar MD ,&nbsp;Austin L. Terwilliger PhD ,&nbsp;Anthony Maresso PhD ,&nbsp;Robert S. Venick MD ,&nbsp;Suzanne V. McDiarmid MD ,&nbsp;John S. Bradley MD","doi":"10.1016/j.jpeds.2026.115005","DOIUrl":"10.1016/j.jpeds.2026.115005","url":null,"abstract":"<div><div>Antimicrobial resistance is life-threatening to pediatric patients with medical complexity who receive multiple courses of broad-spectrum antibiotics. Bacteriophages offer a safe treatment alternative when our antibiotic armamentarium is no longer sufficient. We describe successful use of bacteriophage therapy on a patient with a recalcitrant <em>P</em><em>seudomonas</em> <em>aeruginosa</em> infection after receiving a multiorgan transplant.</div></div>","PeriodicalId":54774,"journal":{"name":"Journal of Pediatrics","volume":"291 ","pages":"Article 115005"},"PeriodicalIF":3.5,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146020852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Time-Series Machine Learning for Prediction of Bronchopulmonary Dysplasia. 时间序列机器学习预测支气管肺发育不良。
IF 3.5 2区 医学 Q1 PEDIATRICS Pub Date : 2026-01-19 DOI: 10.1016/j.jpeds.2026.115003
Divya Chhabra, Jingyang Lin, Jinsheng Pan, Irina Prelipcean, Igor Khodak, Colby L Day, Jack Chang, Xing Qiu, Jiebo Luo, Andrew M Dylag

Objective: To build a time-series machine learning (ML) model that improves bronchopulmonary dysplasia (BPD) prediction compared with published online calculators.

Study design: We used a single-center, extremely low gestational age newborn cohort (inborn, birth year 2016-2021, n = 438). The primary outcome was a 5-level class outcome for BPD as defined by the Neonatal Research Network (NRN) in 2019. Flowsheet data were extracted from the electronic medical record. Time-series data were generated from birth onward, with 14 static and 35 dynamic input attributes. Iterative static (regression) and dynamic (ML) modeling was performed, comparing model performance with the NRN BPD calculator at several time points (postnatal day 1, 3, 7, 14, and 28) and ranking feature leverage at each time point.

Results: Of the original cohort, 92 infants met all inclusion criteria (gestational age 25.6 ± 1.4 weeks). Static models performed comparably with the NRN BPD calculator (area under the curve = 0.7460), improving to 0.7978 with forward/backward selection. In contrast, dynamic long short-term memory (LSTM) models outperformed static models at all time points, reaching a peak area under the curve of 0.8400 on postnatal day 28. LSTM models performed best for no BPD and severe disease/death. Principal component analysis revealed that respiratory support, ventilator settings, supplemental oxygen requirements, medications, and prenatal/postnatal growth were major factors driving BPD severity.

Conclusions: LSTM-based ML time-series analysis substantially outperformed static approaches for predicting BPD and death among extremely low gestational age newborns. Integrating ML methods into clinical applications holds promise for enhancing real-time BPD trajectory mapping.

目的:建立一个时间序列机器学习(ML)模型,与已发表的在线计算器相比较,改进BPD预测。研究设计:我们采用单中心、极低胎龄新生儿队列(elgan,出生年份2016-2021,N=438)。主要结果是新生儿研究网络(NRN)在2019年定义的BPD的5级分类结果。从电子病历中提取流程数据。时间序列数据从出生开始生成,有14个静态输入属性和35个动态输入属性。进行迭代静态(回归)和动态(ML)建模,在几个时间点(出生后[PND] 1、3、7、14和28)将模型性能与NRN BPD计算器进行比较,并在每个时间点对特征利用进行排序。结果:在原始队列中,92名婴儿符合所有纳入标准(胎龄25.6±1.4周)。静态模型的表现与NRN BPD计算器相当(AUC=0.7460),在向前/向后选择时提高到0.7978。相比之下,动态长短期记忆(LSTM)模型在所有时间点上都优于静态模型,在PND 28达到峰值AUC为0.8400。LSTM模型在无BPD和严重疾病/死亡的情况下表现最好。主成分分析(PCA)显示,呼吸支持、呼吸机设置、补充氧气需求、药物和产前/产后生长是影响BPD严重程度的主要因素。结论:基于lstm的ML时间序列分析在预测elgan的BPD和死亡方面明显优于静态方法。将ML方法集成到临床应用中,有望增强实时BPD轨迹映射。
{"title":"Time-Series Machine Learning for Prediction of Bronchopulmonary Dysplasia.","authors":"Divya Chhabra, Jingyang Lin, Jinsheng Pan, Irina Prelipcean, Igor Khodak, Colby L Day, Jack Chang, Xing Qiu, Jiebo Luo, Andrew M Dylag","doi":"10.1016/j.jpeds.2026.115003","DOIUrl":"10.1016/j.jpeds.2026.115003","url":null,"abstract":"<p><strong>Objective: </strong>To build a time-series machine learning (ML) model that improves bronchopulmonary dysplasia (BPD) prediction compared with published online calculators.</p><p><strong>Study design: </strong>We used a single-center, extremely low gestational age newborn cohort (inborn, birth year 2016-2021, n = 438). The primary outcome was a 5-level class outcome for BPD as defined by the Neonatal Research Network (NRN) in 2019. Flowsheet data were extracted from the electronic medical record. Time-series data were generated from birth onward, with 14 static and 35 dynamic input attributes. Iterative static (regression) and dynamic (ML) modeling was performed, comparing model performance with the NRN BPD calculator at several time points (postnatal day 1, 3, 7, 14, and 28) and ranking feature leverage at each time point.</p><p><strong>Results: </strong>Of the original cohort, 92 infants met all inclusion criteria (gestational age 25.6 ± 1.4 weeks). Static models performed comparably with the NRN BPD calculator (area under the curve = 0.7460), improving to 0.7978 with forward/backward selection. In contrast, dynamic long short-term memory (LSTM) models outperformed static models at all time points, reaching a peak area under the curve of 0.8400 on postnatal day 28. LSTM models performed best for no BPD and severe disease/death. Principal component analysis revealed that respiratory support, ventilator settings, supplemental oxygen requirements, medications, and prenatal/postnatal growth were major factors driving BPD severity.</p><p><strong>Conclusions: </strong>LSTM-based ML time-series analysis substantially outperformed static approaches for predicting BPD and death among extremely low gestational age newborns. Integrating ML methods into clinical applications holds promise for enhancing real-time BPD trajectory mapping.</p>","PeriodicalId":54774,"journal":{"name":"Journal of Pediatrics","volume":" ","pages":"115003"},"PeriodicalIF":3.5,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12833681/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146020834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Accelerated Weaning of Opioids to Reduce Pharmacologic Exposure for Neonatal Opioid Withdrawal Syndrome: A Randomized Clinical Trial 加速阿片类药物断奶以减少新生儿阿片类药物戒断综合征的药物暴露:一项随机临床试验。
IF 3.5 2区 医学 Q1 PEDIATRICS Pub Date : 2026-01-17 DOI: 10.1016/j.jpeds.2026.114992
Abbot R. Laptook MD , Adam Czynski DO , Rouba Chahine PhD , Rachel G. Greenberg MD MB MHS , P. Brian Smith MD , Erica Oliveira BA , Jenna Gabrio MPH , Barry Eggleston MS , Abhik Das PhD , Jeannette Lee PhD , Barry Lester PhD , Dave Clark DrPH, MPH , Michele Walsh MD , Helen Ko MD , Clare Campbell Asher MD , Hayley Friedman MD , Samuel Gentle MD , Karishma Rao MD , Anup Katheria MD , Kristen Benninger MD , Jessica Snowden MD

Objective

To determine if newborns receiving morphine or methadone as the primary pharmacologic treatment for neonatal opioid withdrawal syndrome (NOWS) tolerate and receive fewer days of opioid using an accelerated wean protocol (15% decrements) compared with using a slower wean protocol (10% decrements).

Study design

Newborns ≥36 weeks of gestation receiving morphine or methadone for NOWS were enrolled in a pragmatic blinded, randomized multicenter trial. Newborns underwent protocol-driven weaning with decreasing opioid doses of either 15% or 10% decrements. Weaning was encouraged every 24 hours, and if signs of NOWS worsened, the preceding dose was resumed. To maintain blinding, the last 3 dose levels of the 15% decrements were placebo. The primary outcome was the number of days of opioid treatment from the first weaning dose to cessation of opioids.

Results

Slow enrollment prompted early trial closure; 189 newborns were randomized, 98 (51.9%) to 15% decrements (mean ± SD, 38.8 ± 1.2 weeks gestation, 59.8% male) and 91 (48.1%) to 10% decrements (38.8 ± 1.3 weeks gestation, 61.5% male). Morphine was used most commonly. Intention-to-treat analysis included all but 4 infants withdrawn in the 15% decrement group. The durations of opioid treatment during weaning were 8.2 (7.2, 9.5) (adjusted mean [95% CI]) and 11.2 (9.7, 12.9) days for 15% and 10% decrement groups, respectively (P < .001). Adverse events were few in both groups.

Conclusion

Pharmacologic treatment of NOWS using an accelerated wean protocol (15% decrements) was well tolerated with fewer days of opioid treatment compared with 10% decrements.

Trial registration

ClinicalTrials.gov number: NCT04214834
目的:确定接受吗啡或美沙酮作为新生儿阿片类戒断综合征(NOWS)的主要药物治疗的新生儿是否耐受和使用加速断奶方案(减少15%)比使用慢速断奶方案(减少10%)接受更少的阿片类药物天数。研究设计:≥36孕周的新生儿接受吗啡或美沙酮治疗NOWS,纳入一项实用的盲法、随机多中心试验。新生儿接受方案驱动的断奶,阿片类药物剂量减少15%或10%。鼓励每24小时断奶一次,如果NOWS症状恶化,则恢复前一剂量。为了保持盲性,15%减量的最后3个剂量水平为安慰剂。主要结局是阿片类药物治疗的天数,从第一次断奶剂量到阿片类药物停止。结果:入组缓慢导致试验提前结束;189例新生儿随机分组,减少98例(51.9%)~ 15%(平均±标准差,38.8±1.2周,男性59.8%),减少91例(48.1%)~ 10%(38.8±1.3周,男性61.5%)。吗啡是最常用的。意向治疗分析包括15%减量组中除4名婴儿外的所有婴儿。15%减量组和10%减量组在断奶期间阿片类药物治疗的持续时间分别为8.2(7.2,9.5)(调整后的平均值[95%可信区间])和11.2(9.7,12.9)天(p结论:与减量10%组相比,使用加速断奶方案(减量15%)的药物治疗NOWS耐受性良好,阿片类药物治疗天数更少。
{"title":"Accelerated Weaning of Opioids to Reduce Pharmacologic Exposure for Neonatal Opioid Withdrawal Syndrome: A Randomized Clinical Trial","authors":"Abbot R. Laptook MD ,&nbsp;Adam Czynski DO ,&nbsp;Rouba Chahine PhD ,&nbsp;Rachel G. Greenberg MD MB MHS ,&nbsp;P. Brian Smith MD ,&nbsp;Erica Oliveira BA ,&nbsp;Jenna Gabrio MPH ,&nbsp;Barry Eggleston MS ,&nbsp;Abhik Das PhD ,&nbsp;Jeannette Lee PhD ,&nbsp;Barry Lester PhD ,&nbsp;Dave Clark DrPH, MPH ,&nbsp;Michele Walsh MD ,&nbsp;Helen Ko MD ,&nbsp;Clare Campbell Asher MD ,&nbsp;Hayley Friedman MD ,&nbsp;Samuel Gentle MD ,&nbsp;Karishma Rao MD ,&nbsp;Anup Katheria MD ,&nbsp;Kristen Benninger MD ,&nbsp;Jessica Snowden MD","doi":"10.1016/j.jpeds.2026.114992","DOIUrl":"10.1016/j.jpeds.2026.114992","url":null,"abstract":"<div><h3>Objective</h3><div>To determine if newborns receiving morphine or methadone as the primary pharmacologic treatment for neonatal opioid withdrawal syndrome (NOWS) tolerate and receive fewer days of opioid using an accelerated wean protocol (15% decrements) compared with using a slower wean protocol (10% decrements).</div></div><div><h3>Study design</h3><div>Newborns ≥36 weeks of gestation receiving morphine or methadone for NOWS were enrolled in a pragmatic blinded, randomized multicenter trial. Newborns underwent protocol-driven weaning with decreasing opioid doses of either 15% or 10% decrements. Weaning was encouraged every 24 hours, and if signs of NOWS worsened, the preceding dose was resumed. To maintain blinding, the last 3 dose levels of the 15% decrements were placebo. The primary outcome was the number of days of opioid treatment from the first weaning dose to cessation of opioids.</div></div><div><h3>Results</h3><div>Slow enrollment prompted early trial closure; 189 newborns were randomized, 98 (51.9%) to 15% decrements (mean ± SD, 38.8 ± 1.2 weeks gestation, 59.8% male) and 91 (48.1%) to 10% decrements (38.8 ± 1.3 weeks gestation, 61.5% male). Morphine was used most commonly. Intention-to-treat analysis included all but 4 infants withdrawn in the 15% decrement group. The durations of opioid treatment during weaning were 8.2 (7.2, 9.5) (adjusted mean [95% CI]) and 11.2 (9.7, 12.9) days for 15% and 10% decrement groups, respectively (<em>P</em> &lt; .001). Adverse events were few in both groups.</div></div><div><h3>Conclusion</h3><div>Pharmacologic treatment of NOWS using an accelerated wean protocol (15% decrements) was well tolerated with fewer days of opioid treatment compared with 10% decrements.</div></div><div><h3>Trial registration</h3><div><span><span>ClinicalTrials.gov</span><svg><path></path></svg></span> number: NCT04214834</div></div>","PeriodicalId":54774,"journal":{"name":"Journal of Pediatrics","volume":"292 ","pages":"Article 114992"},"PeriodicalIF":3.5,"publicationDate":"2026-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146004807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Duration of Antibiotic Therapy for Gram-Negative Bloodstream Infections in the Neonatal Intensive Care Unit 新生儿重症监护病房中革兰氏阴性血流感染的抗生素治疗时间。
IF 3.5 2区 医学 Q1 PEDIATRICS Pub Date : 2026-01-17 DOI: 10.1016/j.jpeds.2026.114993
Colleen J. Djordjevich PharmD, BCPPS , Jacqueline Magers PharmD, BCPS , Joseph B. Cantey MD, MPH , Pavel Prusakov PharmD, BCPPS, BCIDP , Pablo J. Sánchez MD

Objective

To evaluate the effectiveness and safety of short (≤8 days) vs long (≥9 days) duration of antibiotic therapy for uncomplicated gram-negative (GN) bloodstream infections (BSI) among infants in the neonatal intensive care unit (NICU).

Study design

Retrospective analysis of infants treated for GN BSI at 7 NICUs within 2 health care systems. Infants were identified by review of positive blood cultures from the microbiology laboratory and electronic health records. Patients were excluded if they had polymicrobial BSI, meningitis/osteomyelitis/endocarditis, or died before completion of therapy as ordered. The primary outcome was recurrence of BSI with the same organism within 14 days of discontinuation of effective antimicrobial therapy (“treatment failure.”) Secondary outcomes were emergence of GN multidrug-resistant organisms (MDRO) and mortality.

Results

In all, 76 infants (39 short duration; 37 long duration) were included; 15 (38%) and 25 (69%) infants had a central venous catheter in place at onset of BSI in the short and long duration groups, respectively. Escherichia coli was the most common pathogen in both groups (27 [69%], short duration; 18 [49%], long duration). There were 2 recurrences of BSI, both in the long duration group. Among study infants, 5 had a subsequent GN MDRO infection; all were in the long duration group.

Conclusions

Treatment failure and GN MDROs occurred among infants who received ≥9 days of antibiotic therapy. Shorter antibiotic duration (≤8 days) appeared to be an effective intervention that could reduce antibiotic exposure and its adverse consequences among NICU infants.
目的:评估短期(≤8天)与长期(≥9天)抗生素治疗新生儿重症监护病房(NICU)婴儿无并发症革兰氏阴性(GN)血流感染(BSI)的有效性和安全性。研究设计:回顾性分析2个医疗保健系统7个NICU中接受GN BSI治疗的婴儿。通过审查微生物实验室和电子健康记录的阳性血液培养来确定婴儿。如果患者患有多微生物性BSI、脑膜炎/骨髓炎/心内膜炎或在治疗完成前死亡,则排除。主要终点是停止有效抗菌药物治疗后14天内BSI复发(“治疗失败”)。次要结局是GN的出现、多药耐药菌(MDRO)和死亡率。结果:共纳入76例婴儿(短期39例,长期37例);在短时间组和长时间组中,分别有15名(38%)和25名(69%)婴儿在BSI发病时放置中心静脉导管。两组中最常见的病原菌为大肠杆菌(27例[69%],病程短;18例[49%],病程长)。长时间组有2例BSI复发。在研究婴儿中,5名随后发生了GN MDRO感染;所有人都在长时间组。结论:接受抗生素治疗≥9天的婴儿出现治疗失败和GN mdro。缩短抗生素持续时间(≤8天)似乎是一种有效的干预措施,可以减少新生儿重症监护病房婴儿的抗生素暴露及其不良后果。
{"title":"Duration of Antibiotic Therapy for Gram-Negative Bloodstream Infections in the Neonatal Intensive Care Unit","authors":"Colleen J. Djordjevich PharmD, BCPPS ,&nbsp;Jacqueline Magers PharmD, BCPS ,&nbsp;Joseph B. Cantey MD, MPH ,&nbsp;Pavel Prusakov PharmD, BCPPS, BCIDP ,&nbsp;Pablo J. Sánchez MD","doi":"10.1016/j.jpeds.2026.114993","DOIUrl":"10.1016/j.jpeds.2026.114993","url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate the effectiveness and safety of short (≤8 days) vs long (≥9 days) duration of antibiotic therapy for uncomplicated gram-negative (GN) bloodstream infections (BSI) among infants in the neonatal intensive care unit (NICU).</div></div><div><h3>Study design</h3><div>Retrospective analysis of infants treated for GN BSI at 7 NICUs within 2 health care systems. Infants were identified by review of positive blood cultures from the microbiology laboratory and electronic health records. Patients were excluded if they had polymicrobial BSI, meningitis/osteomyelitis/endocarditis, or died before completion of therapy as ordered. The primary outcome was recurrence of BSI with the same organism within 14 days of discontinuation of effective antimicrobial therapy (“treatment failure.”) Secondary outcomes were emergence of GN multidrug-resistant organisms (MDRO) and mortality.</div></div><div><h3>Results</h3><div>In all, 76 infants (39 short duration; 37 long duration) were included; 15 (38%) and 25 (69%) infants had a central venous catheter in place at onset of BSI in the short and long duration groups, respectively. <em>Escherichia coli</em> was the most common pathogen in both groups (27 [69%], short duration; 18 [49%], long duration). There were 2 recurrences of BSI, both in the long duration group. Among study infants, 5 had a subsequent GN MDRO infection; all were in the long duration group.</div></div><div><h3>Conclusions</h3><div>Treatment failure and GN MDROs occurred among infants who received ≥9 days of antibiotic therapy. Shorter antibiotic duration (≤8 days) appeared to be an effective intervention that could reduce antibiotic exposure and its adverse consequences among NICU infants.</div></div>","PeriodicalId":54774,"journal":{"name":"Journal of Pediatrics","volume":"292 ","pages":"Article 114993"},"PeriodicalIF":3.5,"publicationDate":"2026-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146004565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Repetitive Motor Behaviors in Non-Autistic Toddlers 非自闭症幼儿的重复性运动行为。
IF 3.5 2区 医学 Q1 PEDIATRICS Pub Date : 2026-01-17 DOI: 10.1016/j.jpeds.2026.114994
Monique Moore Hill MA , Devon Gangi PhD , Shy Maqbool BS , Rachel Ni MS , Chandni Parikh PhD , Sally Ozonoff PhD

Objective

To evaluate repetitive motor behaviors (RMBs) in non-autistic toddlers using direct observational methods.

Study design

This cohort study assessed RMBs in a community sample of 679 toddlers at 24 and 36 months of age. Initial analyses examined rates of RMBs in autistic (n = 65) vs nonautistic (n = 614) participants. Subsequent analyses focused on participants without autism, first examining clinical correlates of RMBs in the full non-autistic group and then comparing rates of RMBs in 2 non-autistic subgroups: 104 participants with other developmental concerns (ODC) and 510 participants with no developmental concerns.

Results

A total of 36% of non-autistic children demonstrated RMB at 24 and/or 36 months of age. RMBs were significantly more likely in the ODC (55%) than the no developmental concerns (33%) group. Non-autistic participants with RMBs had significantly lower communication scores at 24 months and, at both ages, significantly higher scores on 2 measures of autism-related symptomatology than those without RMBs; however, group means fell within the average range and effect sizes were small. There were no RMB differences based on sex.

Conclusions

RMBs are not uncommon in 24- to 36-month-old children who do not meet diagnostic criteria for autism. Among non-autistic children, RMBs are most likely to occur in those with other developmental challenges but are also present in some typically developing children. The presence of RMBs in toddlers should be evaluated within the context of Diagnostic and Statistical Manual of Mental Disorders, fifth edition ASD criteria, and RMBs alone without social communication challenges core to ASD should not be viewed as automatically indicative of autism.
目的:采用直接观察法评价非自闭症幼儿的重复性运动行为。研究设计:本队列研究评估了679名24和36个月大的幼儿的重复性运动行为(RMBs)。最初的分析检查了自闭症(n=65)和非自闭症(n=614)参与者的RMBs率。随后的分析集中在没有自闭症的参与者身上,首先检查了完全非自闭症组中RMBs的临床相关性,然后比较了两个非自闭症亚组中RMBs的发生率:104名有其他发展问题(ODC)的参与者和510名没有发展问题(NDC)的参与者。结果:36%的非自闭症儿童在24和/或36个月大时表现出重复性运动行为。人民币在ODC组(55%)的可能性明显高于NDC组(33%)。有RMBs的非自闭症参与者在24个月时的沟通得分显著低于没有RMBs的参与者,在两个年龄段,自闭症相关症状的两项测量得分均显著高于没有RMBs的参与者;然而,组均值落在平均范围内,效应量很小。性别之间没有人民币差异。结论:在不符合自闭症诊断标准的24-36月龄儿童中,RMBs并不罕见。在非自闭症儿童中,RMBs最有可能发生在那些有其他发育挑战的儿童中,但也存在于一些正常发育的儿童中。幼儿中存在的rmb应该在DSM-5 ASD标准的背景下进行评估,如果没有ASD核心的社会沟通挑战,那么单独的rmb不应该被视为自闭症的自动指示。
{"title":"Repetitive Motor Behaviors in Non-Autistic Toddlers","authors":"Monique Moore Hill MA ,&nbsp;Devon Gangi PhD ,&nbsp;Shy Maqbool BS ,&nbsp;Rachel Ni MS ,&nbsp;Chandni Parikh PhD ,&nbsp;Sally Ozonoff PhD","doi":"10.1016/j.jpeds.2026.114994","DOIUrl":"10.1016/j.jpeds.2026.114994","url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate repetitive motor behaviors (RMBs) in non-autistic toddlers using direct observational methods.</div></div><div><h3>Study design</h3><div>This cohort study assessed RMBs in a community sample of 679 toddlers at 24 and 36 months of age. Initial analyses examined rates of RMBs in autistic (n = 65) vs nonautistic (n = 614) participants. Subsequent analyses focused on participants without autism, first examining clinical correlates of RMBs in the full non-autistic group and then comparing rates of RMBs in 2 non-autistic subgroups: 104 participants with other developmental concerns (ODC) and 510 participants with no developmental concerns.</div></div><div><h3>Results</h3><div>A total of 36% of non-autistic children demonstrated RMB at 24 and/or 36 months of age. RMBs were significantly more likely in the ODC (55%) than the no developmental concerns (33%) group. Non-autistic participants with RMBs had significantly lower communication scores at 24 months and, at both ages, significantly higher scores on 2 measures of autism-related symptomatology than those without RMBs; however, group means fell within the average range and effect sizes were small. There were no RMB differences based on sex.</div></div><div><h3>Conclusions</h3><div>RMBs are not uncommon in 24- to 36-month-old children who do not meet diagnostic criteria for autism. Among non-autistic children, RMBs are most likely to occur in those with other developmental challenges but are also present in some typically developing children. The presence of RMBs in toddlers should be evaluated within the context of Diagnostic and Statistical Manual of Mental Disorders, fifth edition ASD criteria, and RMBs alone without social communication challenges core to ASD should not be viewed as automatically indicative of autism.</div></div>","PeriodicalId":54774,"journal":{"name":"Journal of Pediatrics","volume":"292 ","pages":"Article 114994"},"PeriodicalIF":3.5,"publicationDate":"2026-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146004520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of the Supreme Court and State Legislation on Pediatric Diversity Initiatives. 最高法院和州立法对儿科多样性倡议的影响。
IF 3.5 2区 医学 Q1 PEDIATRICS Pub Date : 2026-01-16 DOI: 10.1016/j.jpeds.2026.114991
Michael D Cabana, Samantha R Levano, Pedro A de Alarcon, Xylina D Bean, Loretta Cordova de Ortega, Laura Degnon, Phyllis A Dennery, Lewis R First, Kersten Hildebrandt-Abdikarim, Charles Schleien, Lilia Parra-Roide, Glenn Flores
{"title":"Impact of the Supreme Court and State Legislation on Pediatric Diversity Initiatives.","authors":"Michael D Cabana, Samantha R Levano, Pedro A de Alarcon, Xylina D Bean, Loretta Cordova de Ortega, Laura Degnon, Phyllis A Dennery, Lewis R First, Kersten Hildebrandt-Abdikarim, Charles Schleien, Lilia Parra-Roide, Glenn Flores","doi":"10.1016/j.jpeds.2026.114991","DOIUrl":"10.1016/j.jpeds.2026.114991","url":null,"abstract":"","PeriodicalId":54774,"journal":{"name":"Journal of Pediatrics","volume":" ","pages":"114991"},"PeriodicalIF":3.5,"publicationDate":"2026-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145999725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exception from Informed Consent in Neonatal Research 新生儿研究中知情同意的例外。
IF 3.5 2区 医学 Q1 PEDIATRICS Pub Date : 2026-01-16 DOI: 10.1016/j.jpeds.2026.114999
Jay R. Malone MD, PhD , Elizabeth E. Foglia MD, MSCE , Brian S. Carter MD , Sindhu Srinivas MD, MSCE , F. Sessions Cole MD
{"title":"Exception from Informed Consent in Neonatal Research","authors":"Jay R. Malone MD, PhD ,&nbsp;Elizabeth E. Foglia MD, MSCE ,&nbsp;Brian S. Carter MD ,&nbsp;Sindhu Srinivas MD, MSCE ,&nbsp;F. Sessions Cole MD","doi":"10.1016/j.jpeds.2026.114999","DOIUrl":"10.1016/j.jpeds.2026.114999","url":null,"abstract":"","PeriodicalId":54774,"journal":{"name":"Journal of Pediatrics","volume":"293 ","pages":"Article 114999"},"PeriodicalIF":3.5,"publicationDate":"2026-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145999756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Pediatrics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1